You are here

Article metrics

Article menu

This article has a correction. Please see:

Download PDFPDF

XML
Clinical/translational cancer immunotherapy
Original research
Phase 2 study of pembrolizumab in patients with advanced rare cancers

 

Online download statistics by month:

Online download statistics by month: March 2020 to August 2024

AbstractFullPdf
Mar 202011821182321
Apr 2020980980176
May 202033433498
Jun 202033233290
Jul 202028528768
Aug 202028328161
Sep 202034734768
Oct 202028828865
Nov 202033233373
Dec 202036236274
Jan 2021525525107
Feb 202136336363
Mar 202150750794
Apr 202136836868
May 202124424462
Jun 202124023980
Jul 202130230280
Aug 202121021065
Sep 202140140180
Oct 202122923077
Nov 202146046294
Dec 202130130779
Jan 2022347368106
Feb 2022410417107
Mar 202225326071
Apr 202224325167
May 202221622269
Jun 202221722566
Jul 202218719768
Aug 202226927575
Sep 202215115563
Oct 202217618467
Nov 202221821949
Dec 202219619662
Jan 202318718745
Feb 202323323959
Mar 202319920157
Apr 202315215342
May 202315215231
Jun 202318218246
Jul 202316516955
Aug 202318818843
Sep 202313413745
Oct 202313613935
Nov 202313813852
Dec 202316716750
Jan 202412412753
Feb 202410110137
Mar 2024159165128
Apr 202414614862
May 202414114154
Jun 202412212151
Jul 202413113333
Aug 2024979533
Total14812149363924